Kahl, Sabine
Düsseldorf University Hospital · Deutsches Diabetes-Zentrum e.V. · German Center for Diabetes Research · Heinrich Heine University Düsseldorf
8 papers on CoChatORCID 0000-0003-3172-6050
Most cited papers
- Verified
Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial
Kahl, S., Gancheva, S., Straßburger, K., Herder, C., Machann, J., Katsuyama, H., Kabisch, S., Henkel, E., Kopf, S., Lagerpusch, M., et al. (2020) · Diabetes Care
Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment
Cited by 360
- Verified
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Huttasch, M., Roden, M., & Kahl, S. (2024) · Metabolism
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 169
- Verified
Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease
Pafili, K., Kahl, S., Mastrototaro, L., Strassburger, K., Pesta, D., Herder, C., Pützer, J., Dewidar, B., Hendlinger, M., Granata, C., et al. (2022) · Journal of Hepatology
Adipose Tissue and MetabolismLiver Disease Diagnosis and Treatment
Cited by 67
- Verified
Impaired Hepatic Mitochondrial Capacity in Nonalcoholic Steatohepatitis Associated With Type 2 Diabetes
Gancheva, S., Kahl, S., Pesta, D., Mastrototaro, L., Dewidar, B., Strassburger, K., Sabah, E., Esposito, I., Weiß, J., Sarabhai, T., et al. (2022) · Diabetes Care
Liver Disease Diagnosis and TreatmentMitochondrial Function and Pathology
Cited by 60
- Verified
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction–associated steatohepatitis
Sakuma, I., Gaspar, R. C., Nasiri, A. R., Dufour, S., Kahn, M., Zheng, J., LaMoia, T. E., Guerra, M. T., Taki, Y., Kawashima, Y., et al. (2025) · Proceedings of the National Academy of Sciences
Liver Disease Diagnosis and TreatmentCholesterol and Lipid Metabolism
Cited by 46
- VerifiedRetracted
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease
Sarabhai, T., Kahl, S., Gancheva, S., Mastrototaro, L., Dewidar, B., Pesta, D., Ratter-Rieck, J. M., Bobrov, P., Jeruschke, K., Esposito, I., et al. (2024) · Metabolism
Liver Disease Diagnosis and TreatmentMitochondrial Function and Pathology
Cited by 9
- Verified
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis
Kahl, S., Pützer, J., & Roden, M. (2022) · Seminars in Liver Disease
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 5
- Verified
Hyperglykämie verstärkt die magenentleerungshemmende Wirkung von exogenem GLP-1
Kahl, S. (2015) · Der Diabetologe
Diabetes Treatment and ManagementHelicobacter pylori-related gastroenterology studies
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free